MedPath

Persistent Organic Pollutants and Mechanical Discharge: Limiting the Impact of Bariatric Surgery Through Personalized Adapted Physical Activity

Not Applicable
Recruiting
Conditions
Obesity
Bariatric Surgery Candidate
Interventions
Behavioral: Adapted physical activity with aerobic training [GEA]
Behavioral: Adapted physical activity with strength training [GRM]
Registration Number
NCT06597617
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

For the most severe cases of obesity, recourse to bariatric surgery is the ultimate solution. Although highly beneficial to individual health, this massive loss of body mass could also have negative effects on metabolism and neuromuscular function. Unfortunately, these effects have been relatively little studied in the scientific literature, and are poorly taken into account in patient follow-up when bariatric surgery has been recommended. One of the adverse effects of bariatric surgery is the release into the bloodstream of Persistent Organic Pollutants (POPs) which, are not only persistent, but also bioaccumulative, toxic and mobile. The major problem is that these circulating POPs are linked to a number of adverse side effects, including reproductive disorders, neurobehavioral alterations, metabolic disorders, gut microbiota alterations inflammatory changes and physiological alterations. POP neurotoxicity could also affect psychomotor abilities and neuromuscular function. In addition, the mechanical unloading (i.e., reduced mechanical stress on muscles) induced by loss of body mass, an effect targeted by bariatric surgery and largely beneficial to the health of individuals, could also alter neuromuscular function and potentially alter muscle architecture and contractile properties. Unfortunately, no data are currently available in the scientific literature to confirm or refute these hypotheses. Physical activity-based intervention strategies may be usefull to counteract the effects of mechanical unloading and the release of POPs as suggested in scientific literature. However it is also possible to question which exercise modality should be preferred. Our hypothesis is that eccentric muscle strengthening would better preserve muscle mass and neuromuscular function while limiting the risks associated with POPs release, compared with an aerobic and a control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Adult patient (18-55 years)
  • Patient scheduled for bariatric surgery
  • Patient practicing a leisure-time physical activity < 8 hours of moderate intensity per week or < 4 hours of high intensity per week
  • Presence of effective contraception (hormonal or mechanical)
Exclusion Criteria
  • Patient already involved in another experimental study
  • Pregnant (urine pregnancy test) or breast-feeding women
  • Patient in a particular situation deemed incompatible with the study by the investigator
  • Patients from outside the Alpes-Maritimes and Var departments
  • Patient having received antibiotic treatment during the 3 months preceding the first stool collection
  • Presence of a contraindication to adapted physical activity
  • Presence of a contraindication to neurostimulation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
GEA (Aerobic training)Adapted physical activity with aerobic training [GEA]-
GRM (Strength training)Adapted physical activity with strength training [GRM]-
Primary Outcome Measures
NameTimeMethod
MVC (Maximum Voluntary Contraction)One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Unit used to quantify MVC (Maximum Voluntary Contraction): Nm. Description: MVC will be obtained using an ergometer and force sensors.

Blood concentration for each POP investigatedOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Unit used to quantify blood concentration for each POP (Persistent Organic Pollutant) investigated: ng/g of lipid.

Secondary Outcome Measures
NameTimeMethod
Total POPs blood concentration [∑POPs]One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Total POPs blood concentration \[∑POPs\] (ng/ml) will be obtained with the analysis of a blood sampling by chromatography and spectrometry.

Quantity by POPs categoryOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Quantity by POPs category (ng/ml) will be obtained with the analysis of a blood sampling by chromatography and spectrometry.

Specific and relative muscle strengthOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Specific and relative muscle strength (N m) will be obtained using an ergometer and force sensors.

M-waveOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

M-wave will be obtained using an EMG device.

NAV [Voluntary Activation Level]One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

NAV \[Voluntary Activation Level\] (%) will be obtained using an ergometer, force sensors and a stimulator device

FatigabilityOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Fatigability (Δ N m) will be obtained using an ergometer, force sensors and a muscular fatigue protocol.

Pennation angleOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Pennation angle (°) will be obtained by muscle ultrasound imaging.

Muscle thicknessOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Muscle thickness (mm) will be obtained by muscle ultrasound imaging.

Fascicle lengthOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Fascicle length (mm) will be obtained by muscle ultrasound imaging.

Characterization of gut microbiotaOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Alpha and beta diversity will be obtained by the analysis of feces collected with specific sampling kit.

WeightOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Weigh (kg) will be obtained by using a weight balance.

Fat massOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Fat mass (kg and %) will be obtained by using an impedancemeter.

Lean massOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Lean mass (kg and %) will be obtained by using an impedancemeter.

Body mass index (BMI)One week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Body mass index (kg/m\^2) will be obtained by using weight balance and a height chart.

Waist-to-hip ratioOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Waist-to-hip ratio will be obtained by measuring the waist circumference (cm) and the hip circumference (cm) with the WHO protocol.

Total cholesterolOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Total cholesterol (g/l) will be obtained with blood sampling analysis.

Free cholesterolOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Free cholesterol (g/l) will be obtained with blood sampling analysis.

Total intra-serum lipidsOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Total intra-serum lipids (g/l) will be obtained with blood sampling analysis.

PhospholipidsOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Phospholipids (g/l) will be obtained with blood sampling analysis.

TriglyceridesOne week prior to bariatric surgery, 1 month after bariatric surgery, 4 months after bariatric surgery and 12 months after bariatric surgery.

Triglycerides (g/l) will be obtained with blood sampling analysis.

Trial Locations

Locations (1)

CHU de Nice

🇫🇷

Nice, France

© Copyright 2025. All Rights Reserved by MedPath